DRS Technologies Receives $22 Million Order from The U.S. Army to Build Heavy Ammunition Trailers.

PARSIPPANY, N.J. -- DRS Technologies, Inc. (NYSE: DRS) announced today that it has received a $22 million order to build more than 300 M989A1 Heavy Expanded Mobility Ammunition Trailers (HEMATs). DRS-manufactured HEMATs are being used extensively by Multiple Launch Rocket System (MLRS) battalions deployed to Southwest Asia for Operation Iraqi Freedom.

The order was part of a previously awarded five-year Indefinite Delivery/Indefinite Quantity (IDIQ) contract from the U.S. Army's Tank-Automotive and Armaments Command (TACOM) in Warren, Michigan. The work for this contract is being performed by the company's DRS Sustainment Systems unit in West Plains, Missouri.

"The DRS-built HEMAT continues to prove its value as an important part of military transportation operations in Iraq," said Thomas G. Cornwell, president of the company's Sustainment Systems Segment. "Our trailers provide America's commanders and troops with a high-strength, heavy industrial, stable platform to move critical ammunition across the battlefield, sometimes during dangerous convoy missions, and, thus, ensure military readiness."

The HEMAT is part of the U.S. Army's future force transformation and modularization into combat brigades rather than divisions. The trailer has a heavy industrial payload capacity to transport numerous and extremely heavy MLRS pods, palletized or non-palletized conventional ammunition and fuel bladders, whether on paved, unpaved or cross-country roads.

DRS Technologies, headquartered in Parsippany, New Jersey, is a leading supplier of integrated products, services and support to military forces, intelligence agencies and prime contractors worldwide. The company employs approximately 10,000 people. For more information about DRS Technologies, please visit the company's web site at www.drs.com.